Mizuho Medy Co.,Ltd. (TYO:4595)

Mizuho Medy Revenue

Mizuho Medy had revenue of 1.33B JPY in the quarter ending June 30, 2026, a decrease of -0.15%. This brings the company's total for the last twelve months to 10.82B, up 0.75% year-over-year. In the year 2025, Mizuho Medy had annual revenue of 11.26B, down -1.48%. That makes Mizuho Medy the 25,714th largest company in the world by revenue and 2,745th in Japan.

• Revenue (ttm): 10.82B
• Revenue Growth: +0.75%
• P/S Ratio: 3.03
• Revenue / Employee: 56.05M
• Employees: 193
• Market Cap: 32.74B

Revenue Chart

Chart

Chart

Revenue by Segment

• Hospitals and Practitioner - New Coronavirus Test Drug 6.88B 60.2%
• Hospitals and Practitioner - Other Testing Agents and Equipment 3.19B 27.9%
• Hospitals and Practitioner - Influenza Test Drug 977.00M 8.5%
• Over-the-counter and Other Fields 382.00M 3.3%

Fiscal year ended Dec 31, 2024 See the full Mizuho Medy breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	11.26B	-169.00M	-1.48%
Dec 31, 2024	11.43B	440.00M	4.00%
Dec 31, 2023	10.99B	-6.59B	-37.50%
Dec 31, 2022	17.58B	4.44B	33.83%
Dec 31, 2021	13.14B	8.93B	212.41%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error